Evidence map›Paper›PMID 39609033›Full record

ArticleBMJ open2024

A mindfulness-based, cognitive, social, digital relapse-prevention intervention for youth with depression in Australia: study protocol for a randomised controlled trial of Rebound.

Shaminka N Mangelsdorf, Daniela Cagliarini, Yong Yi Lee, Cathrine Mihalopoulos, Virginia Liu, Lee Valentine, Sarah Bendall, Peter Koval, Simon D'Alfonso, Christopher Davey and 13 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Shaminka N MangelsdorfOrygen, Parkville, Victoria, Australia.
Daniela CagliariniOrygen, Parkville, Victoria, Australia daniela.cagliarini@orygen.org.au.ORCID http://orcid.org/0009-0009-1461-0567
Yong Yi LeeMonash University Health Economics Group, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Cathrine MihalopoulosMonash University Health Economics Group, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-7127-9462
Virginia LiuOrygen, Parkville, Victoria, Australia.
Lee ValentineOrygen, Parkville, Victoria, Australia.
Sarah BendallOrygen, Parkville, Victoria, Australia.
Peter KovalMelbourne School of Psychological Sciences, The University of Melbourne, Parkville, Victoria, Australia.
Simon D'AlfonsoSchool of Computing and Information Systems, The University of Melbourne, Parkville, Victoria, Australia.
Christopher DaveyDepartment of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
Penni RussonSchool of Languages, Literatures, Cultures and Linguistics, Monash University, Melbourne, Victoria, Australia.
Jess PhillipsSchool of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
Cesar Gonzalez-BlanchCentre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-3181-4731
Brendan PawseyMercy Health, Melbourne, Victoria, Australia.
Richard M RyanInstitute for Positive Psychology and Education, Australian Catholic University, North Sydney, New South Wales, Australia.
Alexandra ParkerOrygen, Parkville, Victoria, Australia.
Sarah HetrickDepartment of Psychological Medicine, The University of Auckland, Auckland, New Zealand.
Simon RiceOrygen, Parkville, Victoria, Australia.
Reeva LedermanSchool of Computing and Information Systems, The University of Melbourne, Parkville, Victoria, Australia.
Helen HerrmanOrygen, Parkville, Victoria, Australia.
Greg MurrayCentre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia.
John GleesonHealthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Australian Catholic University, Fitzroy, Victoria, Australia.
Mario Alvarez-JimenezOrygen, Parkville, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMajor depressive disorder (MDD) causes significant disease burden and functional impairment during adolescence and young adulthood. While most young people recover from their first episode, around two-thirds will experience one or more relapses, which can become more severe and treatment-resistant with each episode. To address relapse in MDD, we developed a moderated online social therapy platform (titled METHODS AND ANALYSIS: This study is a rater-masked randomised controlled trial. The treatment conditions include ETHICS AND DISSEMINATION: Melbourne Health Human Research Ethics Committee (HREC/42967/MH-2018) provided ethics approval for this study. Findings will be made available through scientific journals and forums and to the public via social media and the Orygen website. TRIAL REGISTRATION NUMBER: ANZCTR, ACTRN12619001412123.

Indexed as

Major Depressive DisorderMindfulnessSecondary PreventionAdolescentAdultAustraliaCognitive Behavioral TherapyFemaleHumansMaleRandomized Controlled Trials as TopicYoung AdultDepression & mood disordersPsychosocial InterventionRandomized Controlled Trial

Identifiers

PMID39609033
PMCPMC11603739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.